SIMCERE PHARMAC (Germany) Analysis
| S2P Stock | EUR 1.39 0.01 0.71% |
SIMCERE PHARMAC GRP is overvalued with Real Value of 1.17 and Hype Value of 1.39. The main objective of SIMCERE PHARMAC stock analysis is to determine its intrinsic value, which is an estimate of what SIMCERE PHARMAC GRP is worth, separate from its market price. There are two main types of SIMCERE PHARMAC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect SIMCERE PHARMAC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of SIMCERE PHARMAC's stock to identify patterns and trends that may indicate its future price movements.
The SIMCERE PHARMAC stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and SIMCERE PHARMAC's ongoing operational relationships across important fundamental and technical indicators.
SIMCERE |
SIMCERE Stock Analysis Notes
About 69.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 28th of June 2022.SIMCERE PHARMAC GRP Investment Alerts
| SIMCERE PHARMAC GRP may become a speculative penny stock | |
| SIMCERE PHARMAC GRP had very high historical volatility over the last 90 days | |
| About 69.0% of the company outstanding shares are owned by corporate insiders |
SIMCERE Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.75 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SIMCERE PHARMAC's market, we take the total number of its shares issued and multiply it by SIMCERE PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.SIMCERE Profitablity
SIMCERE PHARMAC's profitability indicators refer to fundamental financial ratios that showcase SIMCERE PHARMAC's ability to generate income relative to its revenue or operating costs. If, let's say, SIMCERE PHARMAC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, SIMCERE PHARMAC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of SIMCERE PHARMAC's profitability requires more research than a typical breakdown of SIMCERE PHARMAC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1. Technical Drivers
As of the 24th of December, SIMCERE PHARMAC has the risk adjusted performance of 0.0234, and Coefficient Of Variation of 4488.6. In connection with fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of SIMCERE PHARMAC GRP, as well as the relationship between them. Please validate SIMCERE PHARMAC GRP jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if SIMCERE PHARMAC is priced adequately, providing market reflects its prevalent price of 1.39 per share.SIMCERE PHARMAC GRP Price Movement Analysis
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to SIMCERE PHARMAC GRP price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
SIMCERE PHARMAC Outstanding Bonds
SIMCERE PHARMAC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SIMCERE PHARMAC GRP uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SIMCERE bonds can be classified according to their maturity, which is the date when SIMCERE PHARMAC GRP has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
SIMCERE PHARMAC Predictive Daily Indicators
SIMCERE PHARMAC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SIMCERE PHARMAC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.39 | |||
| Day Typical Price | 1.39 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
SIMCERE PHARMAC Forecast Models
SIMCERE PHARMAC's time-series forecasting models are one of many SIMCERE PHARMAC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SIMCERE PHARMAC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SIMCERE PHARMAC to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for SIMCERE Stock analysis
When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |